| Date | Title | | | 02/04/10 | Inspire Announces Webcast of Presentation at BIO CEO Conference| DURHAM, N.C., Feb 04, 2010 (BUSINESS WIRE) -- Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that
Inspire senior management will present at the BIO CEO & Investor
Conference Tuesday, February 9, 2010 at 11:00 am ET in New York City.
The webcast of the presentation will be available on Inspire's web site
at www.inspirepharm.com.
An archived version of the webcast presentation will also be available
through this link for a limited time fol... |
|  | | 01/21/10 | Inspire Announces Results of Phase 3 PROLACRIA(TM) Trial for Dry Eye| - Primary and Secondary Endpoints Not Met -DURHAM, N.C., Jan 21, 2010 (BUSINESS WIRE) -- Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that its Phase 3 clinical trial (Trial 03-113) of PROLACRIA(TM) (diquafosol tetrasodium ophthalmic solution) 2% for the treatment of dry eye disease did not meet its primary endpoint (p = 0.526) or its secondary endpoint (p = 0.368).
"We have provided the top-line results from this trial to our partner Allergan and we will be conducting a thoroug... |
| | | 01/07/10 | Inspire Announces Webcast of Presentation at J.P. Morgan Healthcare
Conference| DURHAM, N.C., Jan 07, 2010 (BUSINESS WIRE) -- Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today that Inspire
senior management will present at the 28th Annual J.P. Morgan
Healthcare Conference on Thursday, January 14, 2010 at 12:00 pm local
time in San Francisco, CA.
The webcast of the presentation will be available on Inspire's web site
at www.inspirepharm.com.
An archived version of the webcast presentation will also be available
throu... |
| |
|
